SEC Form 4 · accession 0001472343-15-000059
Roka BioScience, Inc. · ROKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Sobieski
Officer — SVP & Chief Financial Officer
Period of report
Jun 6, 2015
Accepted (ET)
Jun 9, 2015 · 9:11 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472343
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per share | Jun 6, 2015 | F | 280 | $2.52 | D | 284,072 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction represents the withholding of shares received upon the vesting of restricted stock to cover the associated tax obligations.